In a free society, individuals should be free to care for their physical well-being as they see fit, which includes the freedom to choose the medical treatments they think best. Such liberty does not open the door for fraud or abuse any more than does a free market in other products. In fact, informed consent by patients will become more sophisticated as the market for information about medical treatments becomes more free and open.

More on FDA and Drug Regulation

Commentary

The Genetics Revolution Challenge and How to Incentivize Biomedical Research

By Arnold Kling. The American. June 30, 2014.

Obamacare For Lunch?

By Patrick J. Michaels. Forbes.com. April 11, 2014.

Vaccination and Free Will

By Jeffrey A. Singer. Reason. March 25, 2014.

Cato Studies

Avoiding Medicare’s Pharmaceutical Trap

By Doug Bandow. Policy Analysis No. 556. November 30, 2005.

Treating Doctors as Drug Dealers: The DEA’s War on Prescription Painkillers

By Ronald T. Libby. Policy Analysis No. 545. June 6, 2005.

Health Care Regulation: A $169 Billion Hidden Tax

By Christopher J. Conover. Policy Analysis No. 527. October 4, 2004.

Public Filings

Ter Beek v. City of Wyoming

By Robert Mikos. Legal Briefs. August 20, 2013.

IMS Health v. Sorrell

By Ilya Shapiro. Legal Briefs. July 14, 2009.

Legalizing Prescription Drug Importation

By Roger Pilon. Testimony. January 26, 2005.

Cato Reviews & Journals

FDA’s Animal Food Regulation Is for the Birds

Jerry Ellig and Richard A. Williams. Regulation. Summer 2014.

Electronic Cigarettes at a Regulatory Crossroads

Thomas A. Hemphill. Regulation. Fall 2013.

Small Farms, Big Costs

Sofie E. Miller and Cassidy B. West. Regulation. Fall 2013.

Events

The Kidney Sellers: A Journey of Discovery in Iran

Featuring Michael D. Tanner. March 26, 2014. Book Forum.

Drug Reimportation: The Free-Market Solution

Featuring . September 20, 2004. Capitol Hill Briefing.

Resolved: Congress Should Remove the Ban on Drug Reimportation

Featuring Roger Pilon. March 30, 2004. Policy Forum.